The Judiciary is the third branch of government. As with the Executive and Legislature, the public has a right to see and know and understand the functioning of this branch. That is why India, like every other democracy, has embraced the concept of open court proceedings and trials, except in those situations where, for security or other compelling reasons, in camera hearings are required. In the Mirajkar case ( Naresh Shridhar...
More »SEARCH RESULT
World Bank to infuse $152m to boost UP’s ailing health sector
-The Times of India In a bid to induce a fresh life into the ailing health services delivery system in Uttar Pradesh, the World Bank has signed a $152 million deal with the Central and UP governments. The funds will be used to finance the government's efforts to improve the efficiency, quality, and accountability of health services in the state. The project, called the Uttar Pradesh Health Systems Strengthening Project (UPHSSP) for...
More »To fix BPL, nix CPL-P Sainath
To get the Below Poverty Line figures in perspective, we need to closely monitor the numbers driving the Corporate Plunder Line. One Tendulkar makes the big scores. The other wrecks the averages. The Planning Commission clearly prefers Suresh to Sachin. Using Professor Tendulkar's methodology, it declares that there's been another massive fall in poverty. Yes, another (“more dramatic in the rural areas”). “Record Fall in Poverty” reads one headline. The record...
More »Drug trials: Irked NHRC issues notices to Centre and Andhra Pradesh government-M Suchitra
Says respond else face action Annoyed by the non-submission of reports regarding illegal clinical trials of breast cancer drug, the National Human Rights Commission (NHRC) has issued notices to the Union health ministry and the Andhra Pradesh government. It has asked the Centre and the state government to respond within six weeks or face action. The commission had in June last year sent notices to the Union health secretary, secretary of the...
More »India patent bypass delivers life-saving blow against cancer by Raja Murthy
India's decision this month to produce Germany-based multinational Bayer's anti-cancer drug Nexavar, in the first use of "compulsory licensing" in South Asia, will save lives but also raises intricate questions. Under the compulsory licensing process, a government can under World Trade Organization (WTO) rules bypass a patent owner's rights after three years and order the manufacture and sale of life-saving medicines at much cheaper cost than by obtaining the medicine from...
More »